<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00994760</url>
  </required_header>
  <id_info>
    <org_study_id>FT-1301-401-DE</org_study_id>
    <nct_id>NCT00994760</nct_id>
  </id_info>
  <brief_title>Efficacy and Tolerability of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients Older Than 18 Years</brief_title>
  <acronym>GENISIS</acronym>
  <official_title>A Prospective Non-interventional/Observational Patient Cohort Study on the Efficacy of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Takeda</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Takeda</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study was to evaluate the safety and efficacy of intranasal fentanyl spray in
      cancer patients over four weeks, especially during cancer-related breakthrough pain (BTP)
      attacks. The fentanyl spray was applied into the nose by a metered-spray device. The study
      was to provide further data on pharmacoeconomic efficiency of intranasal fentanyl spray.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Dose of Instanyl</measure>
    <time_frame>during therapy with Instanyl (planned: 28 days)</time_frame>
    <description>Initially prescribed dose/ most efficient single dose of Instanyl at study end</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Physician: Degree of Maximum Pain Intensity During the Last Days/ Since the Last Examination</measure>
    <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
    <description>Scale: 0=no, 1=mild, 2=moderate, 3=strong, 4=very strong, 5=extreme</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Physician: Assessment of Breakthrough Pain Therapy (Initial Visit: Previous/Last Visit: Instanyl)</measure>
    <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
    <description>Scale: 1=very good, 2=good, 3=satisfactory, 4=poor, 5=very poor, 6=insufficient</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Physician: To What Extent Did Your Expectations in Instanyl Have Met? (Last Visit)</measure>
    <time_frame>after therapy with Instanyl (planned: 4 weeks)</time_frame>
    <description>5=completely, 4=for the most part, 3=partially, 2= more or less, 1=rather not, 0=not at all</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Physician: To What Extent Changes Have Occurred Induced by the Treatment of Breakthrough Pain With Instanyl With Respect to ... (at Last Visit)</measure>
    <time_frame>after therapy with Instanyl (at last visit)</time_frame>
    <description>Scale: -3= very much improved, -2= much improved, -1= improved, 0= comparable, 1= worsened, 2= much worsened ,3= very much worsened</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Physician: What is the Current Treatment Needs of Your Patient Regarding ...</measure>
    <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
    <description>Scale: 0=no, 1=low, 2=medium, 3=high</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physician: Degree of Relief of Breakthrough Pain Achieved by Instanyl at Study End</measure>
    <time_frame>after therapy with Instanyl (planned: 4 weeks)</time_frame>
    <description>0=no reduction, 1=slight, 2=medium, 3=strong, 4=very strong, 5=complete</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient: How Many Episodes of Pain You Experience on Average?</measure>
    <time_frame>initial visit (before start of therapy with Instanyl)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient: Description of Pain at Initial Visit</measure>
    <time_frame>initial visit (before start of therapy with Instanyl)</time_frame>
    <description>0=no pain, 10= most intense pain imaginable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient: How do You Feel Today?</measure>
    <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
    <description>Scale: 1=very bad, 2=bad, 3=mediocre, 4=good, 5=very good</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient: To What Extent Your Present Condition is Affected by Your Pain Attacks?</measure>
    <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
    <description>Scale: 0=not at all, 10=completely</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient: Modified Pain Disability Index (mPDI) - Sum - Score (Complete Questionnaires Only)</measure>
    <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
    <description>Scale: 0=no impairment, 70=complete impairment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient: Quality-of-Life-Impairment by Pain =QLIP - Sum - Score (Complete Questionnaires Only)</measure>
    <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
    <description>Scale: 0=complete impairment, 43=no impairment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient: Quality-of-Life-Impairment by Pain =QLIP - Sum - Score (Complete Questionnaires Only) Conspicuous ≤20</measure>
    <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
    <description>0= conspicuous ≤20
1= inconspicuous &gt;20</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient: Marburg Questionnaire on Habitual Health (MQHH): Sum - Score (Complete Questionnaires Only)</measure>
    <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
    <description>Scale: 0=worst, 5=best</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient: Marburg Questionnaire on Habitual Health (MQHH): Sum - Score (Complete Questionnaires Only) Conspicuous &lt;1.5</measure>
    <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
    <description>conspicuous score &lt;1.5 inconspicuous score ≥1.5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient: Degree of Relief of Breakthrough Pain Achieved by Instanyl at Study End</measure>
    <time_frame>after therapy with Instanyl (planned: 4 weeks)</time_frame>
    <description>0=no reduction, 1=slight, 2=medium, 3=strong, 4=very strong, 5=complete</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient: Assessment of Breakthrough Pain Therapy (Initial Visit: Previous/Last Visit: Instanyl)</measure>
    <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
    <description>Scale: 1=very good, 2=good, 3=satisfactory, 4=poor, 5=very poor, 6=insufficient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient: To What Extent Did Your Expectations in Instanyl Have Met With Respect to ... (Last Visit)</measure>
    <time_frame>after therapy with Instanyl (planned: 4 weeks)</time_frame>
    <description>5=completely, 4=for the most part, 3=partially, 2=more or less, 1=rather not, 0=not at all</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient: To What Extent Changes Have Occurred Induced by the Treatment of Breakthrough Pain With Instanyl With Respect to ...(at Last Visit)</measure>
    <time_frame>after therapy with Instanyl (at last visit)</time_frame>
    <description>Scale: -3= very much improved, -2= much improved, -1= improved , 0= comparable, 1= worsened, 2= much worsened, 3= very much worsened</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Caregiver: Degree of Relief of Breakthrough Pain Achieved by Instany at Study End</measure>
    <time_frame>after therapy with Instanyl (planned: 4 weeks)</time_frame>
    <description>0=no reduction, 1=slight, 2=medium, 3=strong, 4=very strong, 5=complete</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Caregiver: Assessment of Breakthrough Pain Therapy by Instanyl (Last Visit)</measure>
    <time_frame>after therapy with Instanyl (first/last visit)</time_frame>
    <description>Scale: 1=very good, 2=good, 3=satisfactory, 4=poor, 5=very poor, 6=insufficient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Caregiver: To What Extent Changes Have Occurred Induced by the Treatment of Breakthrough Pain With Instanyl With Respect to ... (at Last Visit)</measure>
    <time_frame>after therapy with Instanyl (at last visit)</time_frame>
    <description>Scale: -3= very much improved, -2= much improved, -1= improved , 0= comparable, 1= worsened, 2= much worsened, 3= very much worsened</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Caregiver: To What Extent the Treatment Needs of Your Patient Has Changed by the Use of Instanyl Regarding ...</measure>
    <time_frame>after therapy with Instanyl (last visit)</time_frame>
    <description>Scale: -3= very much less, -2= much less, -1= less, 0=comparable, 1= more, 2= much more, 3= very much more</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">131</enrollment>
  <condition>Breakthrough Pain</condition>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>GENISIS</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Instanyl (Intranasal Fentanyl)</intervention_name>
    <description>This was an observational study. Therefore, the physician decided about dosage according to individual needs.</description>
    <arm_group_label>GENISIS</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Outpatients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  decision to start treatment with intranasal fentanyl spray

          -  written informed consent

        Exclusion criteria:

          -  criteria as defined in the Summary of Product Characteristics (Fachinformation Chapter
             4.3)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr. Thomas D. Bethke, PhD; MD</last_name>
    <role>Study Director</role>
    <affiliation>Nycomed Deutschland GmbH, 78467 Konstanz, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Adendorf</city>
        <zip>21365</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Aichach</city>
        <zip>86551</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Albstadt-Ebingen</city>
        <zip>72458</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Albstadt</city>
        <zip>72458</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Altenkirchen</city>
        <zip>57610</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Aschaffenburg</city>
        <zip>63743</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Aschersleben</city>
        <zip>06449</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Augsburg</city>
        <zip>86150</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Augsburg</city>
        <zip>86163</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Backnang</city>
        <zip>71522</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Bad Bevensen</city>
        <zip>29545</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Bad Dürkheim</city>
        <zip>67098</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Bad Liebenstein</city>
        <zip>36448</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Bad Pyrmont</city>
        <zip>31812</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Bad Schwalbach</city>
        <zip>65307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Badel</city>
        <zip>39624</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Bademühlen</city>
        <zip>27404</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Bautzen</city>
        <zip>02625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Berlin</city>
        <zip>10317</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Berlin</city>
        <zip>10409</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Berlin</city>
        <zip>10437</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Berlin</city>
        <zip>10713</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Berlin</city>
        <zip>10715</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Berlin</city>
        <zip>10999</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Berlin</city>
        <zip>12107</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Berlin</city>
        <zip>12627</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Berlin</city>
        <zip>13055</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Bochum</city>
        <zip>44801</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Bonn</city>
        <zip>53177</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Brandenburg/Havel</city>
        <zip>14776</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Braunschweig</city>
        <zip>38100</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Bremen</city>
        <zip>28329</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Brühl</city>
        <zip>50321</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Burg/Fehmarn</city>
        <zip>23769</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Burg</city>
        <zip>39288</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Burscheid</city>
        <zip>51399</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Butzbach</city>
        <zip>35510</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Böblingen</city>
        <zip>71034</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Coburg</city>
        <zip>96450</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Cochem</city>
        <zip>56812</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Cottbus</city>
        <zip>03050</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Cuxhaven</city>
        <zip>27472</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Cuxhaven</city>
        <zip>27474</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Dessau-Roßlau</city>
        <zip>06846</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Dresden</city>
        <zip>01127</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Dresden</city>
        <zip>01309</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Duisburg</city>
        <zip>47137</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40589</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Essen</city>
        <zip>45326</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Etzenricht</city>
        <zip>92694</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Fehmarn</city>
        <zip>23769</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Frankfurt</city>
        <zip>60311</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Frankfurt</city>
        <zip>60313</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Frankfurt</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Freiburg</city>
        <zip>79108</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Friedberg</city>
        <zip>86316</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Geesthacht</city>
        <zip>21502</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Großheirath-Rossach</city>
        <zip>96269</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Göppingen</city>
        <zip>73033</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Görlitz</city>
        <zip>02826</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Gütersloh</city>
        <zip>33330</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Hachenburg</city>
        <zip>57627</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Hainburg</city>
        <zip>63512</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Halle</city>
        <zip>06110</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Halle</city>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Hamburg</city>
        <zip>20095</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Hamburg</city>
        <zip>22765</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Hameln</city>
        <zip>31785</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Hannover</city>
        <zip>30161</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Hannover</city>
        <zip>30167</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Heidelberg</city>
        <zip>69115</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Hellenthal</city>
        <zip>53940</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Herne</city>
        <zip>44625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Herzlake</city>
        <zip>49770</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Hohberg-Hofweiler</city>
        <zip>77749</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Hohberg</city>
        <zip>77749</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Holzminden</city>
        <zip>37603</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Husum</city>
        <zip>25813</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Iserlohn</city>
        <zip>58638</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Itzehoe</city>
        <zip>25524</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Jerichow</city>
        <zip>39319</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Kaiserslautern</city>
        <zip>67655</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Karlsbad</city>
        <zip>76307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Katzhütte</city>
        <zip>98746</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Kevelaar</city>
        <zip>47625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Kiel</city>
        <zip>24106</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Kiel</city>
        <zip>24149</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Kirchberg</city>
        <zip>08107</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Koblenz</city>
        <zip>56068</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Koblenz</city>
        <zip>56072</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Krefeld</city>
        <zip>47798</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Krefeld</city>
        <zip>47799</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Krefeld</city>
        <zip>47803</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Köln</city>
        <zip>50733</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Köln</city>
        <zip>50935</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Köln</city>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Köln</city>
        <zip>50996</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Köln</city>
        <zip>50997</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Köln</city>
        <zip>51065</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Köln</city>
        <zip>51103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Köthen</city>
        <zip>06366</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Laatzen</city>
        <zip>30880</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Lage/Lippe</city>
        <zip>32791</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Landshut</city>
        <zip>84036</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Leipzig</city>
        <zip>04159</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Leverkusen</city>
        <zip>51381</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Ludwigshafen</city>
        <zip>67071</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Magdeburg</city>
        <zip>39110</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Magdeburg</city>
        <zip>39112</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Magdeburg</city>
        <zip>39116</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Mainz</city>
        <zip>55116</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Mannheim</city>
        <zip>63167</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Mannheim</city>
        <zip>68165</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Mayen</city>
        <zip>56727</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Meinersen</city>
        <zip>38536</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>München</city>
        <zip>80538</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Nastätten</city>
        <zip>56355</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Naumburg</city>
        <zip>06618</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Neubrandenburg</city>
        <zip>17022</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Neubrandenburg</city>
        <zip>17033</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Neuss</city>
        <zip>41460</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Neustadt</city>
        <zip>01844</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Neustadt</city>
        <zip>67434</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Nordhorn</city>
        <zip>48529</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Olpe</city>
        <zip>57462</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Osloß</city>
        <zip>38557</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Osnabrück</city>
        <zip>49074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Osnabrück</city>
        <zip>49076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Pforzheim</city>
        <zip>75172</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Plate</city>
        <zip>19086</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Plüderhausen</city>
        <zip>73655</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Potsdam-Babelsberg</city>
        <zip>14482</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Potsdam</city>
        <zip>14467</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Pulheim-Stommeln</city>
        <zip>50259</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Quedlinburg</city>
        <zip>06484</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Rheine</city>
        <zip>48431</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Rosenfeld</city>
        <zip>72348</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Rostock</city>
        <zip>18055</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Rostock</city>
        <zip>18107</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Rostock</city>
        <zip>18109</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Sangerhausen</city>
        <zip>06526</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Schleswig</city>
        <zip>24837</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Siegen</city>
        <zip>57072</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Solingen</city>
        <zip>42659</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>St. Michaelisdonn</city>
        <zip>25693</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Stendal</city>
        <zip>39576</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Stuttgart</city>
        <zip>70619</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Tangermünde</city>
        <zip>39590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Ulm</city>
        <zip>89073</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Ulm</city>
        <zip>89075</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Ulm</city>
        <zip>89077</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Varel</city>
        <zip>26316</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Velbert</city>
        <zip>42551</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Villingen-Schwenningen</city>
        <zip>78054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Wedel</city>
        <zip>22880</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Weinsberg</city>
        <zip>74189</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Werdau</city>
        <zip>08412</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Wesendorf</city>
        <zip>29392</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Westhausen</city>
        <zip>73463</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Wiesbaden</city>
        <zip>65189</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Wiesbaden</city>
        <zip>65191</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Wilster</city>
        <zip>25554</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Zwickau</city>
        <zip>08056</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nycomed Deutschland GmbH</name>
      <address>
        <city>Zwönitz</city>
        <zip>08297</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 5, 2009</study_first_submitted>
  <study_first_submitted_qc>October 13, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 14, 2009</study_first_posted>
  <results_first_submitted>March 13, 2012</results_first_submitted>
  <results_first_submitted_qc>August 27, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 27, 2012</results_first_posted>
  <last_update_submitted>August 27, 2012</last_update_submitted>
  <last_update_submitted_qc>August 27, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 27, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>intranasal fentanyl spray</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breakthrough Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>GENISIS</title>
          <description>Intranasal Fentanyl Spray</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="131"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="107"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>GENISIS</title>
          <description>Intranasal Fentanyl Spray</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="131"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Number of valid cases = 130. Number of valid cases = patients with data available.</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62.1" spread="12.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <description>Number of valid cases = 126. Number of valid cases = patients with data available.</description>
          <units>kgˆm2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23.2" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Tumor diagnosis (malignant neop-lasms ICD10)</title>
          <units>percentage of participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Pain not caused by tumor</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C00-C14 lip, oral cavity and pharynx</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C15-C26 digestive organs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C30-C39 respiratory and intrathoracic organs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C40-C41 bone and articular cartilage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C43-C44 Melanoma and other skin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C50-C50 Mamma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C51-C58 female genital organs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C60-C63 male genital organs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C64-C68 urinary tract</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C73-C75 thyroid and other endocrine glands</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C76-C80 ill-defined, secondary + unspecified sites</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C81-C96 lymphoid, hematopoietic and related tissue</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Karnofsky-index</title>
          <description>score 0= worst (death) , 100= best (no limitation in health)
Number of valid cases = 125. Number of valid cases = patients with data available.</description>
          <units>scores</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58.6" spread="21.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>American Society of Anesthesiologists (ASA)-physical state (2-5)</title>
          <description>ASA = physical status.
state 2: patient with slight generalized disease
state 3: patient with severe generalized disease
state 4: life threatening generalized disease
state 5: moribund patient, unlikly to survive without operation</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>ASA 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ASA 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ASA 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ASA 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ECOG (Eastern Cooperative Oncology Group) performance status (0-4)</title>
          <description>ECOG 0 (fully active) ECOG 1 (restricted in strenuous activity, ambulatory) ECOG 2 (ambulatory, up and about more than 50% of waking hours ECOG 3 (limited selfcare, confined to bed &gt; 50% of waking hours ECOG 4 (completely disabled, no selfcare)</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>ECOG 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ECOG 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ECOG 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ECOG 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ECOG 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Reason for the use of Instanyl</title>
          <description>(multiple reasons possible)</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>No previous BTP medication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Previous BTP medic./Insufficient efficacy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Previous BTP medic./Insufficient speed of action</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Previous BTP medic./Insufficient handling</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Previous BTP medic./Insufficient tolerability</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Previous BTP medic./Other reasons</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Dose of Instanyl</title>
        <description>Initially prescribed dose/ most efficient single dose of Instanyl at study end</description>
        <time_frame>during therapy with Instanyl (planned: 28 days)</time_frame>
        <population>Patients included and treated (without imputation of missing values), intention to treat.
All patients included</population>
        <group_list>
          <group group_id="O1">
            <title>Study Start</title>
          </group>
          <group group_id="O2">
            <title>Study End</title>
          </group>
        </group_list>
        <measure>
          <title>Dose of Instanyl</title>
          <description>Initially prescribed dose/ most efficient single dose of Instanyl at study end</description>
          <population>Patients included and treated (without imputation of missing values), intention to treat.
All patients included</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="131"/>
                <count group_id="O2" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>50 µg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75"/>
                    <measurement group_id="O2" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>100 µg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>200 µg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>400 µg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Physician: Degree of Maximum Pain Intensity During the Last Days/ Since the Last Examination</title>
        <description>Scale: 0=no, 1=mild, 2=moderate, 3=strong, 4=very strong, 5=extreme</description>
        <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
        <population>All patients included and treated, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases.</population>
        <group_list>
          <group group_id="O1">
            <title>Initial Visit</title>
          </group>
          <group group_id="O2">
            <title>Last Visit</title>
          </group>
        </group_list>
        <measure>
          <title>Physician: Degree of Maximum Pain Intensity During the Last Days/ Since the Last Examination</title>
          <description>Scale: 0=no, 1=mild, 2=moderate, 3=strong, 4=very strong, 5=extreme</description>
          <population>All patients included and treated, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="131"/>
                <count group_id="O2" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Persistent pain (IV: N= 126, LV: N= 116)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" spread="1.1"/>
                    <measurement group_id="O2" value="1.6" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Breakthrough pain (IV: N= 126, LV: N= 115)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" spread="0.9"/>
                    <measurement group_id="O2" value="1.8" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Physician: Degree of Relief of Breakthrough Pain Achieved by Instanyl at Study End</title>
        <description>0=no reduction, 1=slight, 2=medium, 3=strong, 4=very strong, 5=complete</description>
        <time_frame>after therapy with Instanyl (planned: 4 weeks)</time_frame>
        <population>Patients included and treated with valid data (without imputation of missing values), intention to treat.
All patients with valid values at last visit. N= number of valid cases (=114). From the 116 participants analyzed, only 114 participants had valid values at the last visit.</population>
        <group_list>
          <group group_id="O1">
            <title>Last Visit</title>
          </group>
        </group_list>
        <measure>
          <title>Physician: Degree of Relief of Breakthrough Pain Achieved by Instanyl at Study End</title>
          <description>0=no reduction, 1=slight, 2=medium, 3=strong, 4=very strong, 5=complete</description>
          <population>Patients included and treated with valid data (without imputation of missing values), intention to treat.
All patients with valid values at last visit. N= number of valid cases (=114). From the 116 participants analyzed, only 114 participants had valid values at the last visit.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Physician: Assessment of Breakthrough Pain Therapy (Initial Visit: Previous/Last Visit: Instanyl)</title>
        <description>Scale: 1=very good, 2=good, 3=satisfactory, 4=poor, 5=very poor, 6=insufficient</description>
        <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
        <population>All patients included and treated, intention to treat, missing values not imputed.
All patients with valid values ('as observed')= N.</population>
        <group_list>
          <group group_id="O1">
            <title>First Visit (FV): Patients With Previous BTP- Medication Only</title>
          </group>
          <group group_id="O2">
            <title>Last Visit (LV)</title>
          </group>
        </group_list>
        <measure>
          <title>Physician: Assessment of Breakthrough Pain Therapy (Initial Visit: Previous/Last Visit: Instanyl)</title>
          <description>Scale: 1=very good, 2=good, 3=satisfactory, 4=poor, 5=very poor, 6=insufficient</description>
          <population>All patients included and treated, intention to treat, missing values not imputed.
All patients with valid values ('as observed')= N.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>speed of action (FV: N= 45, LV: N= 114)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="1.3"/>
                    <measurement group_id="O2" value="1.7" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>strength of action (FV: N= 45, LV: N= 115)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="1.3"/>
                    <measurement group_id="O2" value="1.8" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>tolerability (FV: N= 44, LV: N= 113)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" spread="1.4"/>
                    <measurement group_id="O2" value="1.7" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>safety (FV: N= 45, LV: N= 114)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9" spread="1.2"/>
                    <measurement group_id="O2" value="1.7" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>handling (FV: N= 45, LV: N= 115)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4" spread="1.4"/>
                    <measurement group_id="O2" value="2.1" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>patient satisfaction (FV: N= 45, LV: N= 116)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2" spread="1.3"/>
                    <measurement group_id="O2" value="1.9" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Physician: To What Extent Did Your Expectations in Instanyl Have Met? (Last Visit)</title>
        <description>5=completely, 4=for the most part, 3=partially, 2= more or less, 1=rather not, 0=not at all</description>
        <time_frame>after therapy with Instanyl (planned: 4 weeks)</time_frame>
        <population>Patients included and treated with valid data (without imputation of missing values), intention to treat.
All patients with valid values at last visit. N= number of valid cases (=110). From the 116 participants analyzed, only 110 participants had valid values at the last visit.</population>
        <group_list>
          <group group_id="O1">
            <title>Physician Last Visit (LV)</title>
          </group>
        </group_list>
        <measure>
          <title>Physician: To What Extent Did Your Expectations in Instanyl Have Met? (Last Visit)</title>
          <description>5=completely, 4=for the most part, 3=partially, 2= more or less, 1=rather not, 0=not at all</description>
          <population>Patients included and treated with valid data (without imputation of missing values), intention to treat.
All patients with valid values at last visit. N= number of valid cases (=110). From the 116 participants analyzed, only 110 participants had valid values at the last visit.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Physician: To What Extent Changes Have Occurred Induced by the Treatment of Breakthrough Pain With Instanyl With Respect to ... (at Last Visit)</title>
        <description>Scale: -3= very much improved, -2= much improved, -1= improved, 0= comparable, 1= worsened, 2= much worsened ,3= very much worsened</description>
        <time_frame>after therapy with Instanyl (at last visit)</time_frame>
        <population>All patients included and treated, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N=number of valid cases.</population>
        <group_list>
          <group group_id="O1">
            <title>GENISIS</title>
            <description>Intranasal Fentanyl Spray</description>
          </group>
        </group_list>
        <measure>
          <title>Physician: To What Extent Changes Have Occurred Induced by the Treatment of Breakthrough Pain With Instanyl With Respect to ... (at Last Visit)</title>
          <description>Scale: -3= very much improved, -2= much improved, -1= improved, 0= comparable, 1= worsened, 2= much worsened ,3= very much worsened</description>
          <population>All patients included and treated, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N=number of valid cases.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Nursing and support efforts (N= 113)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.2" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Autonomy of the patient (N= 113)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.5" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain-related impairment in everyday life (N= 113)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.6" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Quality of patient's life (N= 112)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.5" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Extent of use of other medical services (N= 112)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.1" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Physician: What is the Current Treatment Needs of Your Patient Regarding ...</title>
        <description>Scale: 0=no, 1=low, 2=medium, 3=high</description>
        <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
        <population>All patients included and treated, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases.</population>
        <group_list>
          <group group_id="O1">
            <title>Initial Visit (IV)</title>
          </group>
          <group group_id="O2">
            <title>Last Visit (LV)</title>
          </group>
        </group_list>
        <measure>
          <title>Physician: What is the Current Treatment Needs of Your Patient Regarding ...</title>
          <description>Scale: 0=no, 1=low, 2=medium, 3=high</description>
          <population>All patients included and treated, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="131"/>
                <count group_id="O2" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>persistent pain (IV: N=131, LV: N=112)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="0.8"/>
                    <measurement group_id="O2" value="1.3" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>breakthrough pain (IV: N=130, LV: N=111)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5" spread="0.6"/>
                    <measurement group_id="O2" value="1.2" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>nausea (IV: N=130, LV: N=112)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="0.8"/>
                    <measurement group_id="O2" value="0.9" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>vomiting (IV: N=130, LV: N=112)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="0.9"/>
                    <measurement group_id="O2" value="0.7" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>dyspnoea (IV: N=130, LV: N=111)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="0.9"/>
                    <measurement group_id="O2" value="0.7" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>constipation (IV: N=129, LV: N=112)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="0.9"/>
                    <measurement group_id="O2" value="0.8" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>weakness (IV: N=129, LV: N=112)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="0.8"/>
                    <measurement group_id="O2" value="1.4" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>poor appetite (IV: N=131, LV: N=112)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="0.9"/>
                    <measurement group_id="O2" value="1.4" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>tiredness (IV: N=130, LV: N=112)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="0.8"/>
                    <measurement group_id="O2" value="1.4" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>efforts due to wounds/decubitus (N=130, N=112)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="1.0"/>
                    <measurement group_id="O2" value="0.8" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>need for assistance (IV: N=130, LV: N=111)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="0.9"/>
                    <measurement group_id="O2" value="1.3" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>depressiveness (IV: N=129, LV: N=111)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" spread="0.8"/>
                    <measurement group_id="O2" value="1.1" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>anxiety (IV: N=130, LV: N=112)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" spread="0.8"/>
                    <measurement group_id="O2" value="1.1" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>tension (IV: N=130, LV: N=112)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" spread="0.9"/>
                    <measurement group_id="O2" value="1.2" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>disorientation, confusion (IV: N=130, LV: N=111)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="0.8"/>
                    <measurement group_id="O2" value="0.5" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Problems with organization of care (N=129, N=112)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" spread="1.0"/>
                    <measurement group_id="O2" value="0.8" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overburdening family/environment N=129, N=112</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="1.0"/>
                    <measurement group_id="O2" value="1.0" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient: How Many Episodes of Pain You Experience on Average?</title>
        <time_frame>initial visit (before start of therapy with Instanyl)</time_frame>
        <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases (= 91). From the 95 participants analyzed, only 91 participants had valid values at the last visit.</population>
        <group_list>
          <group group_id="O1">
            <title>First Visit</title>
          </group>
        </group_list>
        <measure>
          <title>Patient: How Many Episodes of Pain You Experience on Average?</title>
          <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases (= 91). From the 95 participants analyzed, only 91 participants had valid values at the last visit.</population>
          <units>episodes per day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient: Description of Pain at Initial Visit</title>
        <description>0=no pain, 10= most intense pain imaginable</description>
        <time_frame>initial visit (before start of therapy with Instanyl)</time_frame>
        <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed') =N.</population>
        <group_list>
          <group group_id="O1">
            <title>Patients at First Visit</title>
          </group>
        </group_list>
        <measure>
          <title>Patient: Description of Pain at Initial Visit</title>
          <description>0=no pain, 10= most intense pain imaginable</description>
          <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed') =N.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Persistent pain in the last 24 hrs on average N=94</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain during the last pain attacks maximally N=93</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.3" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain intensity bearable N= 94</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient: How do You Feel Today?</title>
        <description>Scale: 1=very bad, 2=bad, 3=mediocre, 4=good, 5=very good</description>
        <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
        <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases.
Initial Visit N=94
Last Visit N=83</population>
        <group_list>
          <group group_id="O1">
            <title>Initial Visit</title>
          </group>
          <group group_id="O2">
            <title>Last Visit</title>
          </group>
        </group_list>
        <measure>
          <title>Patient: How do You Feel Today?</title>
          <description>Scale: 1=very bad, 2=bad, 3=mediocre, 4=good, 5=very good</description>
          <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases.
Initial Visit N=94
Last Visit N=83</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="0.7"/>
                    <measurement group_id="O2" value="3.3" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient: To What Extent Your Present Condition is Affected by Your Pain Attacks?</title>
        <description>Scale: 0=not at all, 10=completely</description>
        <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
        <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases.
Initial Visit N=94
Last Visit N=83</population>
        <group_list>
          <group group_id="O1">
            <title>Initial Visit</title>
          </group>
          <group group_id="O2">
            <title>Last Visit</title>
          </group>
        </group_list>
        <measure>
          <title>Patient: To What Extent Your Present Condition is Affected by Your Pain Attacks?</title>
          <description>Scale: 0=not at all, 10=completely</description>
          <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases.
Initial Visit N=94
Last Visit N=83</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.6" spread="1.7"/>
                    <measurement group_id="O2" value="3.8" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient: Modified Pain Disability Index (mPDI) - Sum - Score (Complete Questionnaires Only)</title>
        <description>Scale: 0=no impairment, 70=complete impairment</description>
        <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
        <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases.
Initial Visit N=92
Last Visit N= 80</population>
        <group_list>
          <group group_id="O1">
            <title>Initial Visit</title>
          </group>
          <group group_id="O2">
            <title>Last Visit</title>
          </group>
        </group_list>
        <measure>
          <title>Patient: Modified Pain Disability Index (mPDI) - Sum - Score (Complete Questionnaires Only)</title>
          <description>Scale: 0=no impairment, 70=complete impairment</description>
          <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases.
Initial Visit N=92
Last Visit N= 80</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.9" spread="11.4"/>
                    <measurement group_id="O2" value="29.1" spread="16.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient: Quality-of-Life-Impairment by Pain =QLIP - Sum - Score (Complete Questionnaires Only)</title>
        <description>Scale: 0=complete impairment, 43=no impairment</description>
        <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
        <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases.
Initial Visit N=93
Last Visit N=82</population>
        <group_list>
          <group group_id="O1">
            <title>Initial Visit</title>
          </group>
          <group group_id="O2">
            <title>Last Visit</title>
          </group>
        </group_list>
        <measure>
          <title>Patient: Quality-of-Life-Impairment by Pain =QLIP - Sum - Score (Complete Questionnaires Only)</title>
          <description>Scale: 0=complete impairment, 43=no impairment</description>
          <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases.
Initial Visit N=93
Last Visit N=82</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.3" spread="6.6"/>
                    <measurement group_id="O2" value="24.7" spread="7.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient: Quality-of-Life-Impairment by Pain =QLIP - Sum - Score (Complete Questionnaires Only) Conspicuous ≤20</title>
        <description>0= conspicuous ≤20
1= inconspicuous &gt;20</description>
        <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
        <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases.</population>
        <group_list>
          <group group_id="O1">
            <title>Initial Visit</title>
          </group>
          <group group_id="O2">
            <title>Last Visit</title>
          </group>
        </group_list>
        <measure>
          <title>Patient: Quality-of-Life-Impairment by Pain =QLIP - Sum - Score (Complete Questionnaires Only) Conspicuous ≤20</title>
          <description>0= conspicuous ≤20
1= inconspicuous &gt;20</description>
          <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>QLIP - score (classified):QLIP conspicuous (≤20)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80"/>
                    <measurement group_id="O2" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QLIP - score (classified):QLIP inconspicuous (&gt;20)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient: Marburg Questionnaire on Habitual Health (MQHH): Sum - Score (Complete Questionnaires Only)</title>
        <description>Scale: 0=worst, 5=best</description>
        <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
        <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases.
Initial Visit N=93
Last Visit N=81</population>
        <group_list>
          <group group_id="O1">
            <title>Initial Visit</title>
          </group>
          <group group_id="O2">
            <title>Last Visit</title>
          </group>
        </group_list>
        <measure>
          <title>Patient: Marburg Questionnaire on Habitual Health (MQHH): Sum - Score (Complete Questionnaires Only)</title>
          <description>Scale: 0=worst, 5=best</description>
          <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases.
Initial Visit N=93
Last Visit N=81</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="1.0"/>
                    <measurement group_id="O2" value="2.2" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient: Marburg Questionnaire on Habitual Health (MQHH): Sum - Score (Complete Questionnaires Only) Conspicuous &lt;1.5</title>
        <description>conspicuous score &lt;1.5 inconspicuous score ≥1.5</description>
        <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
        <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases.</population>
        <group_list>
          <group group_id="O1">
            <title>Initial Visit</title>
          </group>
          <group group_id="O2">
            <title>Last Visit</title>
          </group>
        </group_list>
        <measure>
          <title>Patient: Marburg Questionnaire on Habitual Health (MQHH): Sum - Score (Complete Questionnaires Only) Conspicuous &lt;1.5</title>
          <description>conspicuous score &lt;1.5 inconspicuous score ≥1.5</description>
          <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>MQHH - score (classified):conspicuous:score &lt;1.5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62"/>
                    <measurement group_id="O2" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>MQHH - score (classified):inconspicuous:score ≥1.5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient: Degree of Relief of Breakthrough Pain Achieved by Instanyl at Study End</title>
        <description>0=no reduction, 1=slight, 2=medium, 3=strong, 4=very strong, 5=complete</description>
        <time_frame>after therapy with Instanyl (planned: 4 weeks)</time_frame>
        <population>Patients included and treated who filled in the patient's documentation with valid data (without imputation of missing values), intention to treat.
All patients with valid values at last visit. N= number of valid cases (80). From the 83 participants analyzed, only 80 participants had valid values at the last visit.</population>
        <group_list>
          <group group_id="O1">
            <title>Patients at Final Visit</title>
          </group>
        </group_list>
        <measure>
          <title>Patient: Degree of Relief of Breakthrough Pain Achieved by Instanyl at Study End</title>
          <description>0=no reduction, 1=slight, 2=medium, 3=strong, 4=very strong, 5=complete</description>
          <population>Patients included and treated who filled in the patient's documentation with valid data (without imputation of missing values), intention to treat.
All patients with valid values at last visit. N= number of valid cases (80). From the 83 participants analyzed, only 80 participants had valid values at the last visit.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient: Assessment of Breakthrough Pain Therapy (Initial Visit: Previous/Last Visit: Instanyl)</title>
        <description>Scale: 1=very good, 2=good, 3=satisfactory, 4=poor, 5=very poor, 6=insufficient</description>
        <time_frame>before and after therapy with Instanyl (first/last visit)</time_frame>
        <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed').</population>
        <group_list>
          <group group_id="O1">
            <title>First Visit (FV)(Patients With Previous BTP-medication Only)</title>
          </group>
          <group group_id="O2">
            <title>Last Visit (LV)</title>
          </group>
        </group_list>
        <measure>
          <title>Patient: Assessment of Breakthrough Pain Therapy (Initial Visit: Previous/Last Visit: Instanyl)</title>
          <description>Scale: 1=very good, 2=good, 3=satisfactory, 4=poor, 5=very poor, 6=insufficient</description>
          <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed').</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>speed of action (FV: N=33, LV: N=82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" spread="1.1"/>
                    <measurement group_id="O2" value="2.0" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>strength of action (FV: N=33, LV: N=82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" spread="1.2"/>
                    <measurement group_id="O2" value="2.0" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>tolerability (FV: N=33, LV: N=82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="1.1"/>
                    <measurement group_id="O2" value="2.0" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>handling (FV: N=33, LV: N=80)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4" spread="1.3"/>
                    <measurement group_id="O2" value="2.0" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>total satisfaction (FV: N=NA, LV: N=82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">no participants contributed data</measurement>
                    <measurement group_id="O2" value="2.0" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient: To What Extent Did Your Expectations in Instanyl Have Met With Respect to ... (Last Visit)</title>
        <description>5=completely, 4=for the most part, 3=partially, 2=more or less, 1=rather not, 0=not at all</description>
        <time_frame>after therapy with Instanyl (planned: 4 weeks)</time_frame>
        <population>Patients included and treated who filled in the patient's documentation with valid data (without imputation of missing values), intention to treat.
All patients with valid values at last visit. N= number of valid cases.</population>
        <group_list>
          <group group_id="O1">
            <title>Patients at Final Visit</title>
          </group>
        </group_list>
        <measure>
          <title>Patient: To What Extent Did Your Expectations in Instanyl Have Met With Respect to ... (Last Visit)</title>
          <description>5=completely, 4=for the most part, 3=partially, 2=more or less, 1=rather not, 0=not at all</description>
          <population>Patients included and treated who filled in the patient's documentation with valid data (without imputation of missing values), intention to treat.
All patients with valid values at last visit. N= number of valid cases.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>speed of action (N=79)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>strength of action (N=80)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>tolerability (N=78)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>handling (N=79)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>total satisfaction (N=80)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient: To What Extent Changes Have Occurred Induced by the Treatment of Breakthrough Pain With Instanyl With Respect to ...(at Last Visit)</title>
        <description>Scale: -3= very much improved, -2= much improved, -1= improved , 0= comparable, 1= worsened, 2= much worsened, 3= very much worsened</description>
        <time_frame>after therapy with Instanyl (at last visit)</time_frame>
        <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases (=81). From the 83 participants analyzed, only 81 participants had valid values at the last visit.</population>
        <group_list>
          <group group_id="O1">
            <title>Patients at Final Visit</title>
          </group>
        </group_list>
        <measure>
          <title>Patient: To What Extent Changes Have Occurred Induced by the Treatment of Breakthrough Pain With Instanyl With Respect to ...(at Last Visit)</title>
          <description>Scale: -3= very much improved, -2= much improved, -1= improved , 0= comparable, 1= worsened, 2= much worsened, 3= very much worsened</description>
          <population>All patients included and treated who filled in the patient's documentation, intention to treat, missing values not imputed.
All patients with valid values ('as observed'). N= number of valid cases (=81). From the 83 participants analyzed, only 81 participants had valid values at the last visit.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Nursing and support efforts (N= 81)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.0" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Autonomy of the patient (N= 81)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.4" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain-related impairment in everyday life (N= 81)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.3" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Quality of patient's life (N= 81)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.4" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Caregiver: Degree of Relief of Breakthrough Pain Achieved by Instany at Study End</title>
        <description>0=no reduction, 1=slight, 2=medium, 3=strong, 4=very strong, 5=complete</description>
        <time_frame>after therapy with Instanyl (planned: 4 weeks)</time_frame>
        <population>Patients included and treated with caregiver documentation (without imputation of missing values), ITT.
All patients with valid values at last visit. N= number of valid cases (=67). From the 70 participants analyzed, only 67 participants had valid values at the last visit.</population>
        <group_list>
          <group group_id="O1">
            <title>Caregiver at Final Visit</title>
          </group>
        </group_list>
        <measure>
          <title>Caregiver: Degree of Relief of Breakthrough Pain Achieved by Instany at Study End</title>
          <description>0=no reduction, 1=slight, 2=medium, 3=strong, 4=very strong, 5=complete</description>
          <population>Patients included and treated with caregiver documentation (without imputation of missing values), ITT.
All patients with valid values at last visit. N= number of valid cases (=67). From the 70 participants analyzed, only 67 participants had valid values at the last visit.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Caregiver: Assessment of Breakthrough Pain Therapy by Instanyl (Last Visit)</title>
        <description>Scale: 1=very good, 2=good, 3=satisfactory, 4=poor, 5=very poor, 6=insufficient</description>
        <time_frame>after therapy with Instanyl (first/last visit)</time_frame>
        <population>Patients included and treated with caregiver documentation (without imputation of missing values), intention to treat.
All patients with valid values ('as observed'). N= number of valid cases.</population>
        <group_list>
          <group group_id="O1">
            <title>Caregiver at Final Visit</title>
          </group>
        </group_list>
        <measure>
          <title>Caregiver: Assessment of Breakthrough Pain Therapy by Instanyl (Last Visit)</title>
          <description>Scale: 1=very good, 2=good, 3=satisfactory, 4=poor, 5=very poor, 6=insufficient</description>
          <population>Patients included and treated with caregiver documentation (without imputation of missing values), intention to treat.
All patients with valid values ('as observed'). N= number of valid cases.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>speed of action (N=69)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>strength of action (N=69)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>tolerability (N=69)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>safety (N=68)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>handling (N=69)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>patient satisfaction (N=68)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Caregiver: To What Extent Changes Have Occurred Induced by the Treatment of Breakthrough Pain With Instanyl With Respect to ... (at Last Visit)</title>
        <description>Scale: -3= very much improved, -2= much improved, -1= improved , 0= comparable, 1= worsened, 2= much worsened, 3= very much worsened</description>
        <time_frame>after therapy with Instanyl (at last visit)</time_frame>
        <population>Patients included and treated with caregiver documentation (without imputation of missing values), ITT.
All patients with valid values ('as observed') =N.</population>
        <group_list>
          <group group_id="O1">
            <title>Caregiver at Final Visit</title>
          </group>
        </group_list>
        <measure>
          <title>Caregiver: To What Extent Changes Have Occurred Induced by the Treatment of Breakthrough Pain With Instanyl With Respect to ... (at Last Visit)</title>
          <description>Scale: -3= very much improved, -2= much improved, -1= improved , 0= comparable, 1= worsened, 2= much worsened, 3= very much worsened</description>
          <population>Patients included and treated with caregiver documentation (without imputation of missing values), ITT.
All patients with valid values ('as observed') =N.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Nursing and support efforts (N= 69)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.8" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Autonomy of the patient (N= 69)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.2" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain-related impairment in everyday life (N= 69)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.3" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Quality of patient's life (N= 68)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.3" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Extent of use of other medical services (N= 69)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.9" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Caregiver: To What Extent the Treatment Needs of Your Patient Has Changed by the Use of Instanyl Regarding ...</title>
        <description>Scale: -3= very much less, -2= much less, -1= less, 0=comparable, 1= more, 2= much more, 3= very much more</description>
        <time_frame>after therapy with Instanyl (last visit)</time_frame>
        <population>Patients included and treated with caregiver documentation (without imputation of missing values), ITT.
All patients with valid values ('as observed'). N= number of valid cases</population>
        <group_list>
          <group group_id="O1">
            <title>Caregiver at Final Visit</title>
          </group>
        </group_list>
        <measure>
          <title>Caregiver: To What Extent the Treatment Needs of Your Patient Has Changed by the Use of Instanyl Regarding ...</title>
          <description>Scale: -3= very much less, -2= much less, -1= less, 0=comparable, 1= more, 2= much more, 3= very much more</description>
          <population>Patients included and treated with caregiver documentation (without imputation of missing values), ITT.
All patients with valid values ('as observed'). N= number of valid cases</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>persistent pain (N=68)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.2" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>breakthrough pain (N=68)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.8" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>nausea (N=68)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.1" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>vomiting (N=65)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.9" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>dyspnoea (N=66)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.1" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>constipation (N=68)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.8" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>weakness (N=68)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>poor appetite (N=68)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>tiredness (N=67)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.8" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>efforts due to wounds/decubitus (N=68)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.8" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>need for assistance in daily activities (N=68)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.1" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>depressiveness (N=67)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.0" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>anxiety (N=67)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.2" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>tension (N=67)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.1" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>disorientation, confusion (N=67)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.9" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Problems with the organization of care (N=68)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.0" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overburdening family/environment (N=68)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.2" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>First until last visit (planned 4 weeks)</time_frame>
      <desc>Patients included and treated with at least one application of Instanyl</desc>
      <group_list>
        <group group_id="E1">
          <title>All Patients Treated</title>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (14.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Osteosynthesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>2</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Medical Responsible</name_or_title>
      <organization>Nycomed Deutschland GmbH</organization>
      <phone>+49 7531 3666 ext 0</phone>
      <email>clinicaltrials@nycomed.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

